When compared to lung cancer presenting as solid nodule(s), Zhao et al (9) reported that the EGFR mutation rate was higher in solid nodules than in GGOs, especially the subtype mutation of 19 del, agreeing with previous studies (14). This evidence concerns the gene EGFR and lung carcinoma.